Page 4 - வேலூர் கிறிஸ்துவர் மருத்துவ கல்லூரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Supreme Court formed a panel to monitor oxygen allocation in the whole country | COVID-19: ஆக்ஸிஜன் ஒதுக்கீட்டை கண்காணிக்க குழுவை அமைத்தது உச்சநீதிமன்றம்
india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.
womwnsday artilce Women in Medicine: The Founding Ideascutter- Dinamani
dinamani.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dinamani.com Daily Mail and Mail on Sunday newspapers.
It s taken roots: COVID-19 may soon turn endemic in many countries
downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
Controversial homegrown vaccine risks derailing India’s rollout By Chris Kay, Bloomberg News
Published: February 7, 2021, 1:09pm
Share: A health worker inoculates police personnel with the COVID-19 vaccine at a civil hospital in Ahmedabad, India, on January 31, 2021. ( Sam Panthaky/AFP/Getty Images/TNS)
A year ago, Krishna Ella was simply known for running a small Indian pharmaceutical company with a reputation for scientific rigor. Then came the pandemic that put the scientist and his family at the center of one of the world’s loudest furors over a coronavirus vaccine.
In June last year, India’s drug regulator permitted Ella’s firm Bharat Biotech International Ltd. to develop a homegrown vaccine in record time. Since then the company has been buffeted by controversies ranging from unrealistic government schedules to sporadic reports of adverse reactions. Matters came to a head last month after the government approved its shot before the complet
Controversy Swirls Around India’s Homegrown Covid Vaccine Bloomberg 2/3/2021
(Bloomberg)
A year ago, Krishna Ella was simply known for running a small Indian pharmaceutical company with a reputation for scientific rigor. Then came the pandemic that put the scientist and his family at the center of one of the world’s loudest furors over a coronavirus vaccine.
In June last year, India’s drug regulator permitted Ella’s firm Bharat Biotech International Ltd. to develop a homegrown vaccine in record time. Since then the company has been buffeted by controversies ranging from unrealistic government schedules to sporadic reports of adverse reactions. Matters came to a head last month after the government approved its shot before the completion of final human trials.